Lv1
50 积分 2025-10-25 加入
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
16天前
已完结
皖公网安备34019202002308
